XML 44 R11.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Earnings Per Share
9 Months Ended
Jul. 02, 2011
Earnings Per Share  
Earnings Per Share

NOTE 6 - EARNINGS PER SHARE

 

                The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share (in thousands, except per share amounts):

 

               

 

Three Months Ended

 

Nine Months Ended

 

July 2,

 2011

 

July 3, 2010

 

July 2, 2011

 

July 3, 2010

 

 

 

 

 

 

 

 

Basic and Diluted Earnings Per Share:

 

 

 

 

 

 

 

Net income

$     22,040

 

$     24,368

 

$     70,933

 

$     62,926

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

       37,021

 

       40,337

 

       39,135

 

       39,935

Dilutive effect of stock options outstanding

             839

 

             871

 

             788

 

             818

Diluted weighted average shares outstanding

        37,860

 

        41,208

 

        39,923

 

        40,753

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

    Basic

$         0.60

 

$         0.60

 

$         1.81

 

$         1.58

    Diluted

$         0.58

 

$         0.59

 

$         1.78

 

$         1.54

 

 

 

               

 

               For the three and nine months ended July 2, 2011, stock options and stock-settled stock appreciation rights ("SARs") related to approximately 1.1 million and 1.2 million shares, respectively, were outstanding but were not included in the computation of diluted earnings per share because the options' and stock-settled SARs' exercise prices were greater than the average market price of the Company's common shares and, therefore, their effect would be antidilutive.

 

               For the three and nine months ended July 3, 2010, stock options and stock-settled SARs related to approximately 0.8 million and 1.1 million shares, respectively, were outstanding but were not included in the computation of diluted earnings per share because the options' and stock-settled SARs' exercise prices were greater than the average market price of the Company's common shares and, therefore, their effect would be antidilutive.